Header Logo

Connection

KAREN RABIN to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications KAREN RABIN has written about Xenograft Model Antitumor Assays.
KAREN RABIN
Connection Strength
0.091
Xenograft Model Antitumor Assays
  1. Efficacy of NAMPT inhibition in T-cell acute lymphoblastic leukemia. PLoS One. 2025; 20(6):e0324443.
    View in: PubMed
    Score: 0.046
  2. Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia. Leukemia. 2025 Mar; 39(3):555-567.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.